Postnatal Expansion of the Pancreatic β-Cell Mass Is Dependent on Survivin

OBJECTIVE—Diabetes results from a deficiency of functional β-cells due to both an increase in β-cell death and an inhibition of β-cell replication. The molecular mechanisms responsible for these effects in susceptible individuals are mostly unknown. The objective of this study was to determine whether a gene critical for cell division and cell survival in cancer cells, survivin, might also be important for β-cells. RESEARCH DESIGN AND METHODS—We generated mice harboring a conditional deletion of survivin in pancreatic endocrine cells using mice with a Pax-6-Cre transgene promoter construct driving tissue-specific expression of Cre-recombinase in these cells. We performed metabolic studies and immunohistochemical analyses to determine the effects of a mono- and biallelic deletion of survivin. RESULTS—Selective deletion of survivin in pancreatic endocrine cells in the mouse had no discernible effects during embryogenesis but was associated with striking decreases in β-cell number after birth, leading to hyperglycemia and early-onset diabetes by 4 weeks of age. Serum insulin levels were significantly decreased in animals lacking endocrine cell survivin, with relative stability of other hormones. Exogenous expression of survivin in mature β-cells lacking endogenous survivin completely rescued the hyperglycemic phenotype and the decrease in β-cell mass, confirming the specificity of the survivin effect in these cells. CONCLUSIONS—Our findings implicate survivin in the maintenance of β-cell mass through both replication and antiapoptotic mechanisms. Given the widespread involvement of survivin in cancer, a novel role for survivin may well be exploited in β-cell regulation in diseased states, such as diabetes.

[1]  James D. Johnson,et al.  Insulin stimulates primary beta-cell proliferation via Raf-1 kinase. , 2008, Endocrinology.

[2]  C. Wright,et al.  pdx-1 function is specifically required in embryonic beta cells to generate appropriate numbers of endocrine cell types and maintain glucose homeostasis. , 2008, Developmental biology.

[3]  W. Bremner,et al.  Advances in male contraception. , 2008, Endocrine reviews.

[4]  M. C. Jørgensen,et al.  An illustrated review of early pancreas development in the mouse. , 2007, Endocrine reviews.

[5]  L. C. Murtaugh,et al.  Pancreas and beta-cell development: from the actual to the possible , 2006, Development.

[6]  D. Altieri The case for survivin as a regulator of microtubule dynamics and cell-death decisions. , 2006, Current opinion in cell biology.

[7]  R. Medema,et al.  The case for Survivin as mitotic regulator. , 2006, Current opinion in cell biology.

[8]  S. Wheatley,et al.  Separating the Anti-apoptotic and Mitotic Roles of Survivin* , 2006, Journal of Biological Chemistry.

[9]  Seung K. Kim,et al.  Intrinsic Regulators of Pancreatic β-Cell Proliferation , 2006 .

[10]  H. Dziema,et al.  Activation and Maturation of Alloreactive CD4‐Independent, CD8+ Cytolytic T Cells , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[11]  B. Kaina,et al.  DNA damage-induced cell death by apoptosis. , 2006, Trends in molecular medicine.

[12]  P. Serup,et al.  Specifying pancreatic endocrine cell fates , 2006, Mechanisms of Development.

[13]  A. F. Stewart,et al.  Molecular Control of Cell Cycle Progression in the Pancreatic β-Cell , 2006 .

[14]  S. Bonner-Weir,et al.  A switch from MafB to MafA expression accompanies differentiation to pancreatic beta-cells. , 2006, Developmental biology.

[15]  G. Giaccone,et al.  Uncoupling the central spindle-associated function of the chromosomal passenger complex from its role at centromeres. , 2006, Molecular biology of the cell.

[16]  C. Ariyan,et al.  Inhibition of apoptosis by survivin improves transplantation of pancreatic islets for treatment of diabetes in mice , 2006, EMBO reports.

[17]  I. Rooman,et al.  Regulation of pancreatic beta-cell mass. , 2005, Physiological reviews.

[18]  J. Fangusaro,et al.  Essential Role for Survivin in Early Brain Development , 2005, The Journal of Neuroscience.

[19]  M. P. Holloway,et al.  Survivin splice variants regulate the balance between proliferation and cell death , 2005, Oncogene.

[20]  A. Schimmer Inhibitor of Apoptosis Proteins: Translating Basic Knowledge into Clinical Practice , 2004, Cancer Research.

[21]  Senta Georgia,et al.  β cell replication is the primary mechanism for maintaining postnatal β cell mass , 2004 .

[22]  M. P. Holloway,et al.  Aberrant Regulation of Survivin by the RB/E2F Family of Proteins* , 2004, Journal of Biological Chemistry.

[23]  W. Earnshaw,et al.  Chromosomal passengers: the four-dimensional regulation of mitotic events , 2004, Chromosoma.

[24]  P. Gruss,et al.  Conditional inactivation of Pax6 in the pancreas causes early onset of diabetes. , 2004, Developmental biology.

[25]  C. Bakal,et al.  Survivin Loss in Thymocytes Triggers p53-mediated Growth Arrest and p53-independent Cell Death , 2004, The Journal of experimental medicine.

[26]  C. Duckett,et al.  Acute Ablation of Survivin Uncovers p53-dependent Mitotic Checkpoint Functions and Control of Mitochondrial Apoptosis* , 2004, Journal of Biological Chemistry.

[27]  D. Altieri Survivin, versatile modulation of cell division and apoptosis in cancer , 2003, Oncogene.

[28]  Xuebiao Yao,et al.  Direct Interaction between Survivin and Smac/DIABLO Is Essential for the Anti-apoptotic Activity of Survivin during Taxol-induced Apoptosis* , 2003, Journal of Biological Chemistry.

[29]  John Calvin Reed,et al.  HBXIP functions as a cofactor of survivin in apoptosis suppression , 2003, The EMBO journal.

[30]  X. Liu,et al.  Survivin Enhances Aurora-B Kinase Activity and Localizes Aurora-B in Human Cells* , 2003, The Journal of Biological Chemistry.

[31]  S. Pollefeyt,et al.  Deficiency of survivin in transgenic mice exacerbates Fas-induced apoptosis via mitochondrial pathways. , 2002, Gastroenterology.

[32]  C. Rhodes,et al.  Pancreatic β-cell growth and survival – a role in obesity-linked type 2 diabetes? , 2002 .

[33]  D. Altieri,et al.  Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. , 2002, Journal of cell science.

[34]  S. Fukuda,et al.  Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis. , 2001, Blood.

[35]  P. Gruss,et al.  Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eye. , 2000, Genes & development.

[36]  D. Vaux,et al.  Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype , 2000, Current Biology.

[37]  Fengzhi Li,et al.  Pleiotropic cell-division defects and apoptosis induced by interference with survivin function , 1999, Nature Cell Biology.

[38]  P. Pandolfi,et al.  Targeted Disruption of CDK4 Delays Cell Cycle Entry with Enhanced p27Kip1 Activity , 1999, Molecular and Cellular Biology.

[39]  H. Kaneto,et al.  Oxidative stress induces p21 expression in pancreatic islet cells: possible implication in beta-cell dysfunction , 1999, Diabetologia.

[40]  M. Barbacid,et al.  Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia , 1999, Nature Genetics.

[41]  D. Altieri,et al.  A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma , 1997, Nature Medicine.

[42]  S. Bonner-Weir,et al.  Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. , 1997, Endocrinology.

[43]  L. Bouwens,et al.  Islet cell neogenesis in the pancreas , 1996, Virchows Archiv.

[44]  R. Weinberg,et al.  The retinoblastoma protein and cell cycle control , 1995, Cell.

[45]  S. Elledge,et al.  Inhibition of cyclin-dependent kinases by p21. , 1995, Molecular biology of the cell.

[46]  H. C. Kaung Growth dynamics of pancreatic islet cell populations during fetal and neonatal development of the rat , 1994, Developmental dynamics : an official publication of the American Association of Anatomists.

[47]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[48]  S. Elledge,et al.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.

[49]  James M. Roberts,et al.  Cyclin-dependent regulation of G1 in mammalian fibroblasts. , 1993, Science.

[50]  A. Pardee G1 events and regulation of cell proliferation. , 1989, Science.

[51]  R. McEvoy,et al.  Pancreatic insulin-, glucagon-, and somatostatin-positive islet cell populations during the perinatal development of the rat. II. Changes in hormone content and concentration. , 1980, Biology of the neonate.

[52]  Anil Bhushan,et al.  The replication of beta cells in normal physiology, in disease and for therapy. , 2007, Nature clinical practice. Endocrinology & metabolism.

[53]  Seung K. Kim,et al.  Intrinsic regulators of pancreatic beta-cell proliferation. , 2006, Annual review of cell and developmental biology.

[54]  A. F. Stewart,et al.  Molecular control of cell cycle progression in the pancreatic beta-cell. , 2006, Endocrine reviews.

[55]  A. F. Stewart,et al.  Evaluation of beta-cell replication in mice transgenic for hepatocyte growth factor and placental lactogen: comprehensive characterization of the G1/S regulatory proteins reveals unique involvement of p21cip. , 2006, Diabetes.

[56]  A. F. Stewart,et al.  Evaluation of -Cell Replication in Mice Transgenic for Hepatocyte Growth Factor and Placental Lactogen Comprehensive Characterization of the G1/S Regulatory Proteins Reveals Unique Involvement of p21 , 2005 .

[57]  Yuval Dor,et al.  Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. , 2004, Nature.

[58]  Senta Georgia,et al.  Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. , 2004, The Journal of clinical investigation.

[59]  C. Rhodes,et al.  Pancreatic beta-cell growth and survival--a role in obesity-linked type 2 diabetes? , 2002, Trends in molecular medicine.

[60]  S. Bonner-Weir Perspective: Postnatal pancreatic beta cell growth. , 2000, Endocrinology.

[61]  Philippe Soriano Generalized lacZ expression with the ROSA26 Cre reporter strain , 1999, Nature Genetics.

[62]  J. Diebold,et al.  Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. , 1998, The American journal of pathology.

[63]  McEvoy Rc,et al.  Pancreatic insulin-, glucagon-, and somatostatin-positive islet cell populations during the perinatal development of the rat. II. Changes in hormone content and concentration. , 1980 .